Colestipol: Clinical Trials

6 trials of Colestipol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated. 3 Phase 3, 2 Phase 2, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 22Completed 2
Phase 11Terminated 1
Phase 41Completed 1

Follow Colestipol: new trials by email Literature Review of Colestipol trials Research Report on Colestipol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride
teriflunomide, Colestipol - Teriflunomide Elimination, Healthy Volunteers
Phase 1TerminatedDerrick Scott Robertson142015-03-012020-04-03
An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Neratinib, Loperamide, Colestipol - Early Stage HER2+ Breast Cancer
Phase 2CompletedPuma Biotechnology, Inc.5632015-02-012022-05-06
Sorbent Therapy of the Cutaneous Porphyrias
Colestipol - Erythropoietic Protoporphyria
Phase 2 / Phase 3CompletedBrigham and Women's Hospital42011-05-012017-04-25
A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction
Niacin, Colestipol, Ezetimibe - Hyperlipidemia, Hypercholesterolemia
Phase 4CompletedTuscaloosa Research & Education Advancement Corporation302005-05-012014-08-12
Familial Atherosclerosis Treatment Study
lovastatin, colestipol, niacin - Cardiovascular Diseases, Coronary Arteriosclerosis
Phase 3CompletedUniversity of Washington1461984-01-012015-12-03
Cholesterol-Lowering Atherosclerosis Study (CLAS)
colestipol, niacin, diet, fat-restricted - Arterial Occlusive Diseases, Cardiovascular Diseases
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1980-06-012013-12-13

Conditions studied

Cardiovascular Diseases (2)  ·  Coronary Artery Disease (2)  ·  Coronary Disease (2)  ·  Heart Diseases (2)  ·  Myocardial Ischemia (2)  ·  Arterial Occlusive Diseases (1)  ·  Atherosclerosis (1)  ·  Breast Neoplasms (1)  ·  Carotid Artery Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Hypercholesterolemia (1)  ·  Hyperlipidemias (1)  ·  Intracranial Arteriosclerosis (1)  ·  Protoporphyria, Erythropoietic (1)

Sponsors

Brigham and Women's Hospital (1)  ·  Derrick Scott Robertson (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  Puma Biotechnology, Inc. (1)  ·  Tuscaloosa Research & Education Advancement Corporation (1)  ·  University of Washington (1)

Countries

United States (4)  ·  Australia (1)  ·  Austria (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Spain (1)

Top investigators

B. Greg Brown, M.D., Ph.D (1)  ·  David Blankenhorn (1)  ·  Raela B Williford, PharmD (1)  ·  Stanley Azen (1)

Results publications

PMID 32464281, PMID 36702070

NIH funding

2015 (1), P01HL023619 (1), P01HL030086 (1)